Nav: Home

Dietary intake and function in amyotrophic lateral sclerosis: Are they associated?

October 24, 2016

Is what you eat associated with better function and respiratory function for patients with amyotrophic lateral sclerosis (ALS) soon after diagnosis?

A new article published online by JAMA Neurology used data from a study of ALS progression to examine associations between nutritional intake, function and respiratory function at the time of study entry for patients who had ALS symptoms for 18 months or less.

ALS is a severe neurodegenerative disorder that causes atrophy, paralysis and eventually respiratory failure. The median survival time for ALS ranges from 20 to 48 months, although 10 percent to 20 percent of patients can live longer than 10 years.

There is interest in the potential role of nutrition and environmental factors in the pathogenesis (development) of ALS and in disease progression.

The current analysis by Jeri W. Nieves, Ph.D., of the Mailman School of Public Health at Columbia University, New York, and coauthors included 302 patients (178 of them men; average age about 63) with ALS. The analysis relied on nutrient intake reported using a food questionnaire; rating scores were used to measure function; and respiratory function was measured using the percentage of predicted force vital capacity (FVC). Higher rating scores and a higher percentage of FVC indicated better function.

Antioxidant nutrients, foods high in carotenoids, fruits, and vegetable intake appear to be associated with better ALS function at baseline, according to the results.

Authors note their study results cannot establish cause and effect. Also, the study relied on a food questionnaire and those may not always represent a true daily diet.

"Those responsible for nutritional care of the patient with ALS should consider promoting fruit and vegetable intake since they are high in antioxidants and carotenes," the study concludes.
-end-
(JAMA Neurol. Published online October 24, 2016. doi:10.1001/jamaneurol.2016.3401. Available pre-embargo to the media at http://media.jamanetwork.com.)

Editor's Note: The article contains conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

The JAMA Network Journals

Related Amyotrophic Lateral Sclerosis Articles:

Researchers perform thousands of mutations to understand amyotrophic lateral sclerosis
Researchers from IBEC and CRG in Barcelona use a technique called high-throughput mutagenesis to study Amyotrophic Lateral Sclerosis (ALS), with unexpected results.
How to improve multiple sclerosis therapy
Medications currently used to treat multiple sclerosis (MS) can merely reduce relapses during the initial relapsing-remitting phase.
Putting the brakes on lateral root development
Biologists have discovered a cellular transporter that links two of the most powerful hormones in plant development -- auxin and cytokinin -- and shows how they regulate root initiation and progression.
Lateral extra-articular tenodesis reduces hamstring autograft
The addition of lateral extra-articular tenodesis to a hamstring autograft in knee surgery in young active patients significantly reduces graft failure and persistent anterolateral rotatory laxity at two years post operatively.
Obesity worsens disability in multiple sclerosis
Obesity is an aggravating factor in relapsing-remitting multiple sclerosis, the most common form of the disease.
More Amyotrophic Lateral Sclerosis News and Amyotrophic Lateral Sclerosis Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...